- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 754
Bardy pumps in series B funding
Ascension Health and UNC Rex Healthcare have both contributed to a $35.5m round that will support the development of Bardy's lightweight cardiac monitor.
Apr 18, 2019Zapata quantifies $21m series A
The Engine has participated in a $21m series A round for its portfolio company Zapata Computing, a quantum technology spinout of Harvard University.
Apr 18, 2019Sonim sounds out Nasdaq for IPO
Outdoor electronic goods producer Sonim Technologies has filed for a $57.5m initial public offering that would provide exits for Motorola Solutions and JVC Kenwood.
Apr 18, 2019Lyric makes room for Airbnb in $160m round
Short-term accommodation provider Lyric has secured $160m in an Airbnb-led series B round that also featured Tishman Speyer and RXR Realty.
Apr 17, 2019Turning Point directs itself to $167m IPO
Eli Lilly and GSK-backed precision oncology drug developer Turning Point Therapeutics floated at the top of its range while expanding the number of shares it issued.
Apr 17, 2019Applied Therapeutics pushes for public markets
Alexandria Real Estate Equities-backed molecular therapy developer Applied Therapeutics is aiming for $86.3m in its initial public offering.
Apr 17, 2019Corporates affirm Affectiva interest with $26m
Aptiv and CAC Holdings joined corporate venturing units Trend Forward Capital and Motley Fool Ventures in a $26m round that almost doubled the MIT spinout's funding.
Apr 17, 2019Corporates affirm Affectiva interest with $26m
Aptiv and CAC Holdings joined corporate venturing units Trend Forward Capital and Motley Fool Ventures in a $26m round that almost doubled Affectiva's funding.
Apr 17, 2019Cardinal Analytx processes series B funding
Cardinal Analytx has raised $20.6m of a targeted $29.3m, adding to a 2017 series A round that included Premera Blue Cross in 2017.
Apr 17, 2019Happe Spine erects funding round
Based on research at University of Notre Dame, Happe Spine is working on implants for interbody spinal fusion.
Apr 17, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


